X2HK3V9
Insertion Ventricle, Right to New Technology Group 9 with Intracardiac Pacemaker, Dual-Chamber, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | H Insertion |
| Body Part | K Ventricle, Right |
| Approach | 3 Percutaneous |
| Device | V Intracardiac Pacemaker, Dual-Chamber |
| Qualifier | 9 New Technology Group 9 |
Operation Definition
Putting in a nonbiological appliance that monitors, assists, performs, or prevents a physiological function but does not physically take the place of a body part
Procedure Overview
This family covers implanting a nonbiological device into the heart or a blood vessel that monitors or supports a physiological function without replacing any tissue itself. A common example is a leadless cardiac pacemaker, a self-contained capsule placed directly inside a heart chamber through a catheter rather than through a surgically implanted pulse generator with wire leads. The device senses the heart's electrical activity and delivers pacing impulses as needed, addressing slow or irregular heart rhythms.
Because the New Technology section exists to track devices recently approved for distinct reimbursement and outcomes monitoring, these procedures are typically newer catheter-based alternatives to long-established open or lead-based techniques. Patients considering them are often candidates who face higher risk from traditional lead placement, such as those with prior infections or difficult venous access.
Anatomy & Axis Detail
Ventricle, Right
The right ventricle pumps deoxygenated blood into the pulmonary circulation and has a thinner, more crescentic muscular wall than the left ventricle, reflecting the lower pressures of the pulmonary system it serves. Devices inserted into this chamber are typically positioned to interact with its electrical activity or contractile function, and the trabeculated inner surface along with the moderator band must be considered during placement to avoid interference with conduction tissue or entanglement of any leads. Access is most often obtained through a central vein and across the tricuspid valve, so operators account for valve competence during and after the procedure. Because the right ventricle sits just behind the sternum, its anatomic position also influences imaging approaches used to confirm correct device placement.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Intracardiac Pacemaker, Dual-Chamber
This value specifies a leadless intracardiac pacemaker configured to pace and sense in two chambers, typically achieved through wireless communication between separate implanted components rather than a single-chamber leadless device. It is distinguished from single-chamber intracardiac pacemakers by its ability to coordinate atrial and ventricular timing without transvenous leads. This dual-chamber capability extends leadless pacing to patients who previously required conventional lead-based dual-chamber systems.
Qualifier: New Technology Group 9
Group 9 is the seventh-position qualifier used in the New Technology section to mark a device, substance, or technique as belonging to the 2022 annual cohort of new technology add-on codes. It has no clinical meaning of its own beyond that vintage tag, so coders rely on the specific table and body system to know what procedure it applies to. It is distinguished from Group 8 and Group 10 purely by the fiscal year the technology was approved for separate identification.
Coding & Documentation
Coders need the operative note to confirm the specific brand or device named in the New Technology table entry, since these codes are device-specific rather than generic. Documentation should state the approach (typically percutaneous), the target chamber, and confirmation that the device itself performs the monitoring or assistive function rather than serving as a structural replacement. A frequent error is defaulting to the standard Cardiovascular section code for pacemaker or device insertion instead of checking whether the specific model qualifies for a New Technology designation, which can materially change reimbursement. Another common miss is failing to update code selection when a device's New Technology group value changes between annual code set updates.
Commonly Confused With
This is easily confused with standard Insertion procedures coded in the regular Cardiovascular System section, where the distinguishing factor is solely whether the device brand appears in the New Technology reference table for that year. It is also distinct from Replacement, which applies when the device or material takes over the physical role of a body part rather than simply monitoring or assisting it.